Published in J Bacteriol on May 01, 1969
Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev (1987) 6.00
Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance. Bacteriol Rev (1975) 4.00
Transformation of chromosomal and plasmid characters in Staphylococcus aureus. J Bacteriol (1972) 3.91
Methicillin-resistant staphylococci. Clin Microbiol Rev (1988) 3.77
Genetics of staphylococcal enterotoxin B in methicillin-resistant isolates of Staphylococcus aureus. Infect Immun (1979) 3.71
Nucleotide sequence of the type A staphylococcal enterotoxin gene. J Bacteriol (1988) 3.26
Transduction of Methicillin Resistance in Staphylococcus aureus Dependent on an Unusual Specificity of the Recipient Strain. J Bacteriol (1970) 3.21
Nonenteric toxins of Staphylococcus aureus. Microbiol Rev (1979) 2.95
Transformation reveals a chromosomal locus of the gene(s) for methicillin resistance in Staphylococcus aureus. J Bacteriol (1975) 2.83
Identification of a Staphylococcus aureus transposon (Tn4291) that carries the methicillin resistance gene(s). J Bacteriol (1988) 2.42
Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob Agents Chemother (1989) 2.37
Protein A mutants of Staphylococcus aureus. J Bacteriol (1971) 2.32
Absence of circular plasmid deoxyribonucleic acid attributable to a genetic determinant for methicillin resistance in Staphylococcus aureus. J Bacteriol (1973) 2.25
Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus. J Bacteriol (1974) 2.23
Molecular cloning of staphylococcal enterotoxin B gene in Escherichia coli and Staphylococcus aureus. Proc Natl Acad Sci U S A (1985) 2.13
Genetic behavior of the methicillin resistance determinant in Staphylococcus aureus. J Bacteriol (1980) 2.12
Isolation and characterization of a plasmid involved with enterotoxin B production in Staphylococcus aureus. J Bacteriol (1977) 2.06
Transduction and elimination of resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1972) 2.00
Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphylococcus aureus. J Clin Microbiol (2005) 1.99
Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.94
Effect of the prophage and penicillinase plasmid of the recipient strain upon the transduction and the stability of methicillin resistance in Staphylococcus aureus. J Bacteriol (1973) 1.92
Production of high titers of enterotoxins for the routine testing of staphylococci. Appl Microbiol (1970) 1.83
Mutations in prophage phi11 that impair the transducibility of their Staphylococcus aureus lysogens for methicillin resistance. J Bacteriol (1977) 1.78
Chromosomal locus for staphylococcal enterotoxin B. Infect Immun (1978) 1.71
Autolysis of methicillin-resistant and -susceptible Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.69
Genetic basis, epidemiology, and future significance of antibiotic resistance in Staphylococcus aureus: a review. J Clin Pathol (1973) 1.57
Structural analysis of plasmid pSN2 in Staphylococcus aureus: no involvement in enterotoxin B production. J Bacteriol (1982) 1.57
Transduction of methicillin resistance in Staphylococcus aureus: recipient effectiveness and beta-lactamase production. Antimicrob Agents Chemother (1980) 1.51
Plasmid-chromosomal transition of genes important in staphylococcal enterotoxin B expression. Infect Immun (1981) 1.40
Staphylococcal enterotoxin B gene is associated with a discrete genetic element. J Bacteriol (1988) 1.13
Phenotypic suppression of methicillin resistance in Staphylococcus aureus by mutant noninducible penicillinase plasmids. J Bacteriol (1972) 1.00
Recipient characteristics in the transduction of methicillin resistance in Staphylococcus epidermidis. Antimicrob Agents Chemother (1986) 0.94
Identification of cephalosporin-resistant Staphylococcus aureus with the disc diffusion method. Antimicrob Agents Chemother (1972) 0.89
Epidemiology of antibiotic and heavy metal resistance in bacteria: resistance patterns in staphylococci isolated from populations not known to be exposed to heavy metals. Antimicrob Agents Chemother (1975) 0.83
Rapid screening for Staphylococcus aureus infection by measuring enterotoxin B. J Clin Microbiol (1989) 0.76
Plasmids in Staphylococcus aureus. Proc R Soc Med (1973) 0.75
Infective heredity of multiple drug resistance in bacteria. Bacteriol Rev (1963) 19.90
Micro-iodometric assay for penicillinase. Biochem J (1962) 16.45
ANALYSIS BY TRANSDUCTION OF MUTATIONS AFFECTING PENICILLINASE FORMATION IN STAPHYLOCOCCUS AUREUS. J Gen Microbiol (1963) 13.54
Agar layer method for production of high titer phage stocks. Proc Soc Exp Biol Med (1951) 12.04
[Episomes, a proposed term for added genetic elements]. C R Hebd Seances Acad Sci (1958) 9.66
Episome-mediated transfer of drug resistance in Enterobacteriaceae. II. Elimination of resistance factors with acridine dyes. J Bacteriol (1961) 8.57
Acriflavine as an effective agent for eliminating F-factor in Escherichia coli K-12. Nature (1957) 7.20
A new screen test and selective medium for the rapid detection of epidemic strains of Staph. aureus. Lancet (1960) 5.82
Episome-mediated transfer of drug resistance in Enterobacteriaceae. III. Transduotion of resistance factors. J Bacteriol (1961) 5.78
THE EFFECT OF GROWTH AT ELEVATED TEMPERATURES ON SOME HERITABLE PROPERTIES OF STAPHYLOCOCCUS AUREUS. J Gen Microbiol (1964) 5.63
Penicillinase plasmids of Staphylococcus aureus. Fed Proc (1967) 5.62
Serologic studies of staphylococcal enterotoxin. Public Health Rep (1958) 5.42
ELIMINATION OF DRUG RESISTANCE OF STAPHYLOCOCCUS AUREUS BY TREATMENT WITH ACRIFLAVINE. J Bacteriol (1963) 4.41
CO-TRANSDUCTION BY A STAPHYLOCOCCAL PHAGE OF THE GENES RESPONSIBLE FOR PENICILLINASE SYNTHESIS AND RESISTANCE TO MERCURY SALTS. Nature (1964) 4.14
TRANSDUCTION BY STAPHYLOCOCCAL BACTERIOPHAGE. Proc Natl Acad Sci U S A (1959) 4.12
Studies on streptococcal bacteriophages. I. Technique of isolating phage-producing strains. Acta Pathol Microbiol Scand (1955) 3.54
PENICILLINASE-RESISTANT PENICILLINS AND CEPHALOSPORINS. Br Med J (1964) 3.49
PRODUCTION OF LARGE QUANTITIES OF ENTEROTOXIN B AND OTHER STAPHYLOCOCCAL TOXINS ON SOLID MEDIA. Acta Pathol Microbiol Scand (1965) 3.22
HIGH PENICILLINASE PRODUCTION CORRELATED WITH MULTIPLE ANTIBIOTIC RESISTANCE IN STAPHYLOCOCCUS AUREUS. Lancet (1964) 3.10
ELIMINATION OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS BY TREATMENT WITH ACRIFLAVINE. J Bacteriol (1964) 3.03
Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus. J Bacteriol (1962) 2.34
[VARIATIONS UNDER THE INFLUENCE OF ACRIFLAVIN AND TRANSDUCTION OF RESISTANCE TO KANAMYCIN AND CHLORAMPHENICOL IN STAPHYLOCOCCI]. Ann Inst Pasteur (Paris) (1964) 1.89
DRUG RESISTANCE OF STAPHYLOCOCCI. I. TRANSDUCTION OF TETRACYCLINE RESISTANCE WITH PHAGE LYSATES OBTAINED FROM MULTIPLY RESISTANT STAPHYLOCOCCI. J Bacteriol (1965) 1.83
Inactivation of benzylpenicillin and methicillin by hospital staphylococci. Br Med J (1963) 1.43
Regulation of the synthesis of penicillinase in diploids of Staphylococcus aureus. Biochem Biophys Res Commun (1968) 1.30
Transduction of tetracycline resistance in Staphylococci. J Pathol Bacteriol (1962) 1.03
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med (1996) 5.07
Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother (1982) 3.84
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine (1998) 3.10
Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scand J Infect Dis Suppl (1979) 2.66
Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase. Antimicrob Agents Chemother (1999) 2.27
Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.15
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother (1980) 1.95
Transduction of penicillinase production and methicillin resistance-enterotoxin B production in strains of Staphylococcus aureus. J Gen Microbiol (1973) 1.85
Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS (2007) 1.82
Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis (1988) 1.62
Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis (1974) 1.57
Numerical taxonomy and laboratory identification of Bacterionema matruchotii, Rothia dentocariosa, Actinomyces naeslundii, Actinomyces viscosus, and some related bacteria. J Gen Microbiol (1973) 1.56
Production of bactericidal concentrations of hydrogen peroxide by Streptococcus sanguis. Arch Oral Biol (1973) 1.56
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis. Med Microbiol Immunol (1977) 1.55
Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis. Scand J Infect Dis (1975) 1.54
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol (1974) 1.47
Influence of the collection and transport of specimens on the recovery of bacteria from peritonsillar abscesses. J Clin Microbiol (1975) 1.46
Characterization of three different beta-lactamases from the Bacteroides fragilis group. Antimicrob Agents Chemother (1980) 1.45
Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol (2005) 1.41
Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tuber Lung Dis (1995) 1.32
Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods (1995) 1.27
Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis (1993) 1.26
Antibiotic susceptibility of Clostridium species isolated from human infections. Scand J Infect Dis (1975) 1.25
Some properties of coagulase-negative deoxyribonuclease-producing strains of staphylococci from human infections. Med Microbiol Immunol (1976) 1.16
Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. J Antimicrob Chemother (1992) 1.15
Determination of methicillin resistance of Staphylococcus aureus. Heterogeneity and its influence on the disc diffusion method. Scand J Infect Dis (1969) 1.15
Pharmacological and clinical study of bacampicillin in acute peritonsillitis--a comparison with ampicillin. Antimicrob Agents Chemother (1977) 1.14
Validation of nested Bordetella PCR in pertussis vaccine trial. J Clin Microbiol (1996) 1.10
Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate. J Antimicrob Chemother (1994) 1.10
Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill (2014) 1.04
Antibiotics in bone tissues. Methodological and practical aspects. Scand J Infect Dis Suppl (1978) 1.03
Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods (2009) 1.03
Interference between gram-positive microorganisms in dental plaque. J Dent Res (1972) 1.02
In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand J Infect Dis Suppl (1988) 1.02
Characterization and partial purification of staphylococcal delta-lysin. Acta Pathol Microbiol Scand (1968) 1.01
Genetic aspects of methicillin resistance and toxin production in a strain of Staphylococcus aureus. Ann N Y Acad Sci (1971) 0.99
Microbiological aspects on peritonsillar abscesses. Scand J Infect Dis (1976) 0.99
Antibacterial activity of clindamycin and lincomycin in human bone. J Antimicrob Chemother (1977) 0.97
[Resistance determination of bacteria: new classification in sensitive groups--S, I and R]. Lakartidningen (1978) 0.97
Antibacterial activity of cefuroxime in human bone. Scand J Infect Dis (1980) 0.97
Antimicrobial in vitro susceptibility of actinomyces israelii and arachnia propionica. Scand J Infect Dis (1977) 0.95
Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions. Am J Dis Child (1991) 0.95
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment. J Antimicrob Chemother (1996) 0.95
Epidemiological and clinical aspects of methicillin resistance and enterotoxin production in Staphylococcus aureus. Ann N Y Acad Sci (1971) 0.95
Effect of trimethoprim or trimethoprim/sulphamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens. Scand J Infect Dis (1981) 0.94
Susceptibility testing to trimethoprim alone and combined with sulphonamides. Chemotherapy (1980) 0.93
Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime. J Antimicrob Chemother (1991) 0.93
Stimulation of staphylococcal haemolysin production by low concentrations of penicillin. Acta Pathol Microbiol Scand (1966) 0.93
beta-lactamases in bacteroides. Scand J Infect Dis Suppl (1978) 0.92
Regression line analysis of the synergistic effect for the combination of trimethoprim-sulphamethoxazole. Chemotherapy (1971) 0.92
Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012. Eur J Clin Microbiol Infect Dis (2014) 0.91
Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates. J Antimicrob Chemother (1993) 0.90
Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area. Antimicrob Agents Chemother (1999) 0.90
Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am J Dis Child (1992) 0.89
How to make sense of pertussis immunogenicity data. Clin Infect Dis (2001) 0.89
Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp. APMIS (1990) 0.89
Identification of cephalosporin-resistant Staphylococcus aureus with the disc diffusion method. Antimicrob Agents Chemother (1972) 0.89
Comparison of direct and standardized antibiotic susceptibility testing in bacteriuria. Chemotherapy (1981) 0.88
Efficacy of single-dose versus seven-day trimethoprim treatment of cystitis in women: a randomized double-blind study. J Infect Dis (1990) 0.87
Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster. Vaccine (2000) 0.86
Failure to detect cell-associated enterotoxin B in Staphylococcus aureus by immunofluorescence. Appl Microbiol (1972) 0.85
The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Tuber Lung Dis (1992) 0.85
Bacteriuria diagnosis and antibiotic susceptibility testing in a group practice by dipslide techniques. Chemotherapy (1979) 0.84
Purification of staphylococcal enterotoxin B. Acta Pathol Microbiol Scand (1966) 0.83
Female urinary tract infection in primary health care: bacteriological and clinical characteristics. Scand J Infect Dis (1990) 0.83
A DNA hybridization test for detection of Bordetella in nasopharyngeal specimens. Mol Cell Probes (1990) 0.83
The role of biotransformation in the genotoxicity of allylic compounds. Arch Toxicol (1987) 0.82
Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother (1988) 0.82
beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection. Scand J Infect Dis Suppl (1978) 0.82
Evaluation of the adenosine triphosphate test in the diagnosis of urinary tract infection. Eur J Clin Microbiol Infect Dis (1991) 0.82
Evaluation of a disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa. APMIS (1989) 0.82
Influence of medium composition on bacterial susceptibility testing to gentamicin and netilmicin. Scand J Infect Dis Suppl (1980) 0.81
Characterization of beta-lactam-resistant Klebsiella oxytoca isolated in a neonatal intensive care unit. APMIS (1991) 0.81
Phage typing of Staphylococcus aureus from bovine mastitis. A comparison of phages according to Davidson to the conventional phage set. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 0.81
Towards European urinalysis guidelines. Introduction of a project under European Confederation of Laboratory Medicine. Clin Chim Acta (2000) 0.81
Levels of trimethoprim and sulfamethoxazole in human oviduct mucosa and plasma. Acta Obstet Gynecol Scand (1982) 0.79
Interpretation of the agar diffusion method for bacterial susceptibility testing. J Antimicrob Chemother (1981) 0.79
Metabolism of 2,3-dichloro-1-propene in the rat. Consideration of bioactivation mechanisms. Drug Metab Dispos (1988) 0.79
Collection and transport of specimens for anaerobic culture. Infection (1980) 0.79
A genetic study of inducible erythromycin resistance in Staphylococcus aureus. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 0.78
Doxycycline concentration levels in bone, soft tissue and serum after intravenous infusion of doxycycline. A clinical study. Scand J Infect Dis Suppl (1976) 0.78
Extracellular proteins in five clostridial species from human infections. Med Microbiol Immunol (1975) 0.78
Compatibility tests between genetic linkage groups in a strain of Staphylococcus aureus. J Gen Microbiol (1973) 0.77
Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone. Int J Oral Surg (1978) 0.77
Antibacterial susceptibility testing by the dip-slide technique: a methodological evaluation. Chemotherapy (1976) 0.77
Comparative study of netilmicin/tinidazole versus netilmicin/clindamycin in the treatment of severe abdominal infections. Scand J Infect Dis (1984) 0.77
Studies on beta-lactamase in Bacteroides fragilis. Infection (1980) 0.77
Enhancement of staphylococcal pathogenicity in the presence of penicillin. Acta Pathol Microbiol Scand (1966) 0.77
In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984. Scand J Infect Dis (1986) 0.77
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination. Dev Biol Stand (1998) 0.77
Levels of trimethoprim and sulphamethoxazole in human seminal plasma. Andrologia (1977) 0.77
The detection of doxycycline activity in human bone. Scand J Infect Dis Suppl (1976) 0.76